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The William H. Beaumont Medical Research Honor Society is an honorary
research society of medical students that was established in 1935 to
honor Dr. William H. Beaumont, a pioneer in physiology research. The
organization seeks to foster a continuing interest in biomedical research
and to promote its value in the practice of medicine. As a part of this
mission, the Society integrates current research topics in the curriculum;
develops a research journal showcasing GW student research; makes
available information on research opportunities and seminars throughout
the area, including the William T. Gill Summer Fellowship for GW medical
students; and highlights student and faculty research accomplishments at
the annual GW Research Day.
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from the editors. . .

The George Washington University School of
Medicine and Health Sciences (SMHS) is pleased
to invite you to read the third edition of Fusion.
Our 2009 edition showcases a spectrum of student research projects, including basic science
research, clinical research, health policy, and
research abroad. Leading faculty members at The
George Washington University Medical Center
have mentored the majority of the journal’s student authors, from endeavors in a hookworm vaccine clinical trial in Brazil, to exploring cardiac
pathophysiology, to spinal surgery at GW.
This year, we invited physicians’ assistant
students, medical students, and physical therapy
students to submit their research. All 18 research
projects presented in this issue were completed
while students attended SMHS. Student officers
of The William H. Beaumont Medical Research
Honors Society were responsible for the editing
and production of this year’s journal. The editorial board included members from the medical
school classes of 2011 and 2012.
We also have an exciting new addition to the
Beaumont Society’s activities — a Journal Club.
This year, we initiated monthly meetings to
create an arena for students to discuss landmark
research studies. These meetings are led by one of
two members of the Beaumont Society and are
moderated by faculty members including Dean
James L. Scott, MD, FACEP; Dean W. Scott
Schroth, MD, MPH; and Anne Hirshfield, PhD,
our faculty advisor in the Office of Research.
Journal Club meetings allow students to better
understand the clinical relevance of scientific
research and provide them with the opportunity
to critically evaluate the strengths and weaknesses
of various studies. We especially would like to
acknowledge Sarah Brown, Journal Club director,
for her exceptional job launching the Journal
Club. We hope that Journal Club will continue
to be an active and integral part of the Beaumont
Society.
The Office of Student Opportunities, led by
Cynthia Powell and Nancy Campbell, has been
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paramount in introducing students to research
projects throughout the United States as well
as internationally. One such opportunity, the
William T. Gill Summer Fellowship, funded
the basic science and clinical research projects
of many students featured in this year’s journal.
The Dean’s Office and the Office of Student
Opportunities also have created the research track
program, which helps students direct their career
toward academic medicine.
We are most grateful for the continual
encouragement and support of Dean Scott, Dean
Schroth, and Assoc. Vice President Hirshfield
whose guidance helped shape the mission of the
Beaumont Society, as well as the many dedicated
faculty members at GW who mentored our peers.
In particular, we would like to thank Thomas
Kohout, in Medical Center Communications
and Marketing, for his creativity, diligence, and
enthusiasm in assembling this journal. Finally, we
also thank our editorial board for its hard work.
Again, we invite you to share our enthusiasm
for student research, and encourage our peers to
continue careers in academic medicine to advance
patient care in all dimensions, whether in basic
science knowledge, clinical care, or health policy.

Talya Bordin-Wosk, MSII

Amrita Karve, MSII

Enjoy Fusion 2009.

Talya Bordin-Wosk, MS II

Amrita Karve, MS II
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from the dean’s office. . .

New endeavors, like breakthrough research, are inherently
exciting. However, most of the
time, those moments come after
years of struggle by many dedicated individuals. Fusion, now
in its third edition, came from
dedicated work by a number of
people as well. It is my pleasure
to recognize just a few of those
who dedicated their time and
effort to bring this magazine to
you.
This journal was conceived
by medical students in the
William H. Beaumont Medical
Research Honor Society and
I commend them for their
work. Specifically, I want to recognize Talya
Bordin-Wosk and Amrita Karve for their creativity and thoroughness in gathering, editing,
and organizing these projects, and Thomas
Kohout for serving as the managing editor. This
journal would not exist without their hard work
and vision. I also want to thank Associate Vice
President for Health Research Anne Hirshfield,
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PhD, for her guidance and mentorship of the
Beaumont Society and her encouragement of the
students working on this journal. We also are
indebted to the Office of Student Opportunities
which arranged many of these projects for the
students, and the generous supporters of that
office. In addition, none of this would have been
possible without the active involvement of so
many of our faculty in the research and other
activities of our medical students. To all of you, a
collective thank you.
I take great pride in the scientific endeavors
of our students, residents, faculty, and staff. I was
especially delighted to read about their activities
and accomplishments through the experiences
in the pages of Fusion. I hope you share in that
delight as you read on.

James L. Scott, MD
Dean, School of Medicine and Health Sciences,
Professor of Emergency Medicine
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from the research office. . .

On behalf of the students of GW’s William H.
Beaumont Medical Research Honor Society,
I welcome you to peruse the 2009 edition of
Fusion, the third volume of a publication created
by the members of this prestigious honor society.
The Beaumont Society was established at the
GW School of Medicine in 1935 to promote
student research.
You will see from the following pages the
depth of research experiences from our brightest
students, not only on a local level but globally
as well. The commitment to the mission of
healing and discovery is evidenced in the work
showcased throughout this publication. These
students bring their excitement and passion
for learning to you in a way that represents
the opportunities for medical advancement in
various fields. Thus, our citizens will reap the
benefits of their labor in the years ahead.
Fusion is an entirely student run publication
which further highlights the students’ abilities as
promising doctors and researchers. In addition,
we salute the faculty advisors and all those
who have mentored and assisted in any way to
make this publication a reality. We also need
to acknowledge the William T. Gill Summer
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Fellowship, which on a yearly
basis, provides stipends to
eligible students to gain
valuable experience in research
during the summer months.
Wherever their careers
take them we know that the
students of the Beaumont
Society will make their
mark in the medical field
throughout the nation and
world. I am honored to serve
as the Society’s faculty advisor
and am happy to support
these gifted students in their
research endeavors.

Anne N. Hirshfield, PhD
Associate Vice President for Health Research,
Compliance, and Technology Transfer
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basic science. . .
Identifying the Cause of Ectopic Beats
during the Initiation of Cardiac Arrhythmias

Craig Forleiter, MSII

Research Track
Advisor: Narine Sarvazyan,
PhD, associate professor,
Department of Pharmacology
and Physiology,
The George Washington
University School of Medicine
and Health Sciences.

Figure 1: 1a and 1b:
The LAD is delicately dissected
and microcannulated with a
polyimide tube, held in place
with two sutures. Figure 1c:
Custom arrangement designed
to visualize electrophysiological
signals, monitor flow, and
record EKG signals, while
keeping the heart viable.
Figure 1d (images 1–4):
Transmembrane potentials were
imaged with the second camera
to reveal the progression of
action potentials throughout
the epicardial surface of the
heart. Figure 1d (image five):
Low-flow reperfusion yields a
very heterogeneous metabolic
substrate that is prone to
increased incidence of sustained
arrhythmias.
6

Heart disease and its associated
Figure 1a:
complications take the lives of
more than 700,000 Americans
each year, making it the leading
cause of death in this country. It
has long been understood that
time is of the essence when an
individual is in the midst of a
Figure 1b:
myocardial infarction (MI), as the
cardiomyocytes have only hours to
survive without adequate oxygenation and lack the ability to regenerate once they begin to necrose.
Therefore, current standards of
care in cardiac catheterization
have focused on rapid dissoluFigure 1d:
tion of coronary obstructions and
restoration of blood flow to the
myocardium using a variety of
percutaneous coronary interventions (PCI).1
Directly related to this is a well-studied
phenomenon known as “ischemic-reperfusion
injury.” Simply put, it is not only the deprivation
of oxygen that leads to catastrophic metabolic
and ionic changes within the myocytes, but also
the restoration of blood flow which adds further
insult to the already damaged cells. Even in
patients who survive an MI, this phenomenon
increases the risk of life-threatening sustained
arrhythmias and must be carefully monitored.
At The George Washington University
Medical Center, the cardiac research laboratory of Matthew Kay, DSBME, and Narine
Sarvazyan, PhD, has developed a novel rat heart
model of cardiac ischemia and reperfusion. With
the model, coronary flow is carefully controlled
to closely mimic in vivo MI conditions. The
hearts of anesthetized rats are explanted and retrograde perfused through the aorta with an oxygenated nutrient solution that supports the organ
for several hours. The Left Anterior Descending
(LAD) artery is delicately dissected and microcannulated with a polyimide tube (Figures 1a
and 1b). In this way, the flow of solution to the

Figure 1c:

vascular bed supplied by the LAD is intricately
controlled.2
The instrumentation is a custom arrangement designed to visualize electrophysiological
signals, monitor flow, and record EKG signals,
while keeping the heart viable (Furure 1c. A dual
CCD camera system enabled us to collect near
simultaneous data describing the metabolic and
electrical conditions of the heart. We observed
the geometry and degree of ischemia by imaging
the fluorescence of NADH, which accumulates
in the mitochondria of ischemic myocytes. After
staining the heart with a potentiometric probe,
transmembrane potentials were imaged with the
second camera to reveal the progression of action
potentials throughout the epicardial surface of
the heart. At the end of the studies, imaging data
were processed using custom algorithms. We then
examined each data frame in detail to identify the
electrophysiological origins of ectopic beats and
any arrhythmogenic conditions (Figure 1d).3
By subjecting hearts to repeated phases of
local ischemia, low-flow and full-flow reperfusion,
we sought to support the working hypothesis that

Ectopic Beats

Continued on p. 7
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low-flow reperfusion yields a very heterogeneous
metabolic substrate that is prone to increased
incidence of sustained arrhythmias (Figure D, last
image). If proven, one can begin to extrapolate
this hypothesis to a clinical setting: if heightened
excitability of certain myocytes during reperfusion is significantly arrhythmogenic, then perhaps
catherization lab, emergency room, and even CPR
protocols should be amended to consider elevated
myocyte excitability resulting from reperfusion in
addition to the complete restoration of blood flow
to ischemic myocardium.
As the data continue to be analyzed, the lab
is already performing experiments to complement the work that has been accomplished. We
are studying a phenomenon known as “cardiac

steal,” and delving deeper into the origins of
ectopic beats by studying how Purkinje fibers may
participate in their formation. As the only lab in
the world that uses a model and instrumentation
such as this, the lab aims to continue refining its
hypotheses and striving to investigate the problems that will bring clinically applicable science
from the bench-top to the bedside.

References:
1.	Dave RM. Changing the Standard of Care in STEMI

PCI. Cath Lab Digest. 2008; 16(9): 1,8–13.
2.	Swift L, Martell B, Khatri V, Arutunyan A, Sarvazyan N, Kay M.

Controlled regional hypoperfusion in Langendorff
heart preparations. Physiol Meas. 2008; 29(2):269–79.
3.	Kay MW, Swift LM, Martell B, Arutunyan A, Sarvazyan N. Loca-

tions of ectopic beats coincide with spatial gradients
of NADH in a regional model of low-flow reperfusion. Am J Physiol Heart Circ Physiol. 2008; 294(5):
H2400-5.

The Miracle Tree: Studying the Effects
of Moringa Oleifera in Prostate Cancer
According to a survey performed by the National
Center for Cancer and Complementary Medicine
(NCCM) in 2004, 62 percent of adults in the
United States use some form of Complementary
and Alternative Medicine (CAM). Excluding
prayer used specifically for health, biologicallybased therapies are the most popular CAM
method used (22 percent).1 Biologically-based
therapies include supplements, which may contain ingredients such as botanicals, vitamins,
minerals, etc., and are used for a variety of reasons, ranging from overall health maintenance
to disease treatment. However, the full extent of
the effectiveness and safety of most supplements
is unknown, making them potentially harmful
to consumers. The necessity for public knowledge
has resulted in an increasing amount of research
focused on studying the mechanisms and effects
of botanicals. The purpose of my research was to
study the effects of a botanical product, Moringa
oleifera, on prostate cancer. M. oleifera, also
known as “the Miracle Tree,” is a pan-tropical
tree that is used throughout the world in over
300 commercial and medicinal uses, including
water purification and treatments for malnutrition, hypertension, inflammation, diabetes and
cancer.2 However, the mechanisms underlying its
effects in prostate cancer are not known.
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To mimic the microenvironment of human
prostate cancer, prostate epithelial cancer cells
were grown together with prostate stromal cells
but separated by a basement membrane-like film
that allowed for the passage of stromal mediators to epithelial cells. One significant stromal
mediator is TGFβ1, which plays a role in cancer
progression by inducing a reactive stroma that
increases cell proliferation. TGFβ1 overproduction in the prostate is associated with increased
tumor grade and the presence of metastases. An
important hormonal mediator is dehydroepiandrosterone (DHEA), which has been shown
to increase gene expression of prostate-specificantigen (PSA — clinically used as a marker for
prostate cancer) in this TGFβ1-induced reactive
stromal environment.3 The co-cultures of prostate
epithelial and stromal cells were treated with
TGFβ1 and DHEA. They were then treated
with either ethanol or aqueous M. oleifera leaf
extracts with the hypothesis that M. oleifera
would reverse DHEA-induced PSA gene expression. The levels of PSA gene expression were
quantified using RealTime RTPCR.
Combined results from five separate experiments found that, compared to controls treated

Miracle Tree

Christine Lin, MSII

Integrative Medicine Track
Advisor: Julia T. Arnold, PhD
National Center for Cancer and
Alternative Medicine, Endocrine
Section; National Institutes of
Health, Bethesda, Md.

Continued on p. 8
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with only DHEA and TGFβ1, addition of
aqueous extract of M. oleifera to DHEA and
TGFβ1 increased PSA gene expression in epithelial cells, while ethanol extract of M. oleifera to
DHEA and TGFβ1 decreased PSA gene expression. These results suggest that ethanol and
aqueous M. oleifera extracts contained different
compounds that interacted with each other (by
unknown mechanisms) to result in contrasting
effects. This contrast between different extractions of M. oleifera demonstrates the major
challenge in studying phytomedicines. Botanicals
are complex mixtures of variable composition
and unknown active compounds. Protocols for
standardizing extract components to achieve
reproducible results are still being developed.

Nevertheless, the preliminary results of this
research suggest that M. oleifera may have an
effect on PSA gene expression in the prostate.
However, more research is needed to determine
whether M. oleifera is beneficial or detrimental
in treating prostate cancer.

References
1.	National Center for Cancer and Complementary Medicine.

The Use of Complementary and Alternative Medicine in the United States, 2007; Retrieved Oct. 7,
2008, from nccam.nih.gov/news/camsurvey_fs1.htm.
2.	Anwar F, Latif S, Ashraf M, Gilani AH. “Moringa oleifera: A

Food Plant with Multiple Medicinal Uses.” Phytotherapy Research. 2006; 21(1): 17–25.
3.	Gray NE, Liu X, Choi R, Blackman MR, Arnold JT. Endocrine-

Immune-Paracrine Interactions in Prostate Cells
as Targeted by Phytomedicines.” Cancer Prevention
Research. 2009; 2: 134–142.

The Effect of Daclizumab on FoxP3+ T Regulatory
Cells in Multiple Sclerosis

Neha Jakhete, MSI

Research Track
Advisor: Bibiana Bielekova, MD
National Institute of Neurological
Diseases and Stroke,
National Institutes of Health,
Bethesda, Md.
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Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system characterized
by lesions in the brain and spinal cord. Although
there is no doubt that the disease is immunemediated, the immune cells that are pathogenic
and the antigen being targeted are unknown.1
Daclizumab therapy is one of many experimental therapies in MS currently being studied.
The drug contains an antibody against the CD25
subunit of the IL-2 receptor (IL-2R). IL-2 is an
important T cell growth factor that promotes T
cell proliferation and differentiation.2 Blocking
CD25 significantly decreases the binding affinity
of IL-2, shutting down the IL-2 signaling pathways of T cells.3
Only a small proportion of resting T cells
express CD25 and have functioning high affinity
IL-2R. The majority of these are FoxP3+ T
regulatory cells (T-regs). T-regs are dependent on
IL-2 for their in vivo proliferation and survival.4
Therefore, one can hypothesize that blocking
CD25 with Daclizumab, which leads to diminished consumption of IL-2 by T cells, may result
in decreased in vivo proliferation of T-regs and/or
their diminished survival. The question of T-reg
dependency on IL-2 was addressed previously in
mice, where it was shown that in the absence of
IL-2, T-regs can use other cytokines, such as IL-7,
to partially compensate for the lack of survival

signal.4 However, this question was never examined in humans. Consequently we wanted to
assess numbers and in vivo proliferation of T-regs
before and during Daclizumab therapy.
Cryopreserved peripheral blood mononuclear
cells (PBMCs) from 26 MS patients from two
separate clinical trials were used for an evaluation of surface molecules (CD3, CD4, CD8) and
intracellular cytokine stain for FoxP3 and Ki67.
FoxP3 is a T-reg marker and Ki67 is a proliferation marker, both of which bind to the chromatin
in the cell nucleus.2 Three separate time points
were taken to examine the time course effects of
Daclizumab treatment. We included evaluation of
CD127 expression, a sub unit of the IL-7 receptor,
to examine if T cells upregulate CD127 to compensate for the blocked CD25 and inability to
utilize IL-2. Stained PBMCs were analyzed using
the flow cytometer.
Results showed that while T-reg cell numbers
decreased 8.1 percent (p < 0.05), Daclizumab had
no significant effect on their in vivo proliferation.
We did observe that of the proliferating T-reg
cells, there was a 46 percent increase in CD127
expression following treatment with Daclizumab
(p < 0.05).
Because CD25 on T-reg cells is blocked by
Daclizumab, the cells are unable to utilize IL-2

Daclizumab
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(necessary for survival) and subsequently upregulate CD127 expression in an attempt to compensate for the blocked CD25. These findings indicate that human T-regs, like their animal counterparts, may be able to utilize another cytokine
for growth and survival in the absence of IL-2.
Despite the fact that Daclizumab mildly inhibits
T-reg numbers in vivo, its overall effect on brain
inflammation in MS is inhibitory.5 This suggests that either FoxP3+ T-regs are not crucially
important for MS disease process, or despite their
lower numbers, their function is not significantly
inhibited by Daclizumab. These conclusions will
be tested in the future studies.

References
1. 	Keegan BM, Noseworthy JH. Multiple Sclerosis. Ann Rev

Med. 2002; 53:285–302.
2.

Malek TR. The Biology of Interleukin-2. Ann Rev

Immunol. 2008; 26:453–79.
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Doxycycline-mediated Inhibition of Choroidal Neovascularization
Choroidal neovascularization
(CNV) is a pathological process in
which new blood
vessels grow from
preexisting vessels
in the choroid
through Bruch’s
membrane and
invade the normally avascular
subretinal space.
These newly
formed vessels contribute to the accumulation of blood
in the subretinal
space, a condition
Figure 1: Effects of doxycycline on experimental CNV in rats. Rats were fed doxycycline enhanced
that leads to phowater for seven days and then laser injury was performed to induce CNV. Seven days post-laser, animals
toreceptor degenwere euthanized and endothelial cells were labeled with isolectin-IB4 in RPE/choroid flatmounts. Panel A
eration and death.1
shows representative images of isolectin-IB4 vessel staining (blue) in laser lesions from animals treated
The formation of
with the indicated doses of doxycycline. Panel B shows a graphical plot of the quantification of CNV lesion
CNV complexes
volumes of doxycycline-treated rats. Each point in this graph represents the average of three volume
is the hallmark
measurements per lesion. Five animals per condition were analyzed, and n represents the number of lesions.
of exudative ageThe median values are depicted in blue.
related macular
degeneration
(AMD).2 Remodeling of the extracellular matrix
metalloproteinases (MMPs), such as MMP-2
plays a key role in neovascularization during
and MMP-9, and their inhibitors plays an
migration and tubule formation of endothelial
cells.3 The delicate balance between matrix
Doxycycline
Continued on p. 10
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Doxycycline
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important role in this remodeling.4 Doxycycline
is a broad spectrum antibiotic that has antiangiogenic properties and inhibitory activity
against MMPs.5 We investigated the effect of
doxycycline on CNV, on regulation of MMP-2
and MMP-9 and on control of anti-angiogenic
pigment epithelium-derived factor (PEDF).
Doxycycline was orally administered to rats
at 500, 50, 5, and 0.5 mg/kg/day, using nontreated animals as controls. After seven days
of treatment, experimental CNV was induced
using a ND:YAG 532-nm laser (Alcon). Seven
days post-induction, animals were euthanized,
and eyes enucleated. RPE/choroid flat-mounts
were labeled with isolectin IB4 to determine
CNV volumes using confocal microscopy and
VolocityTM software.6 Plasma protein levels of
MMP-2, MMP-9, and PEDF were determined by
ELISA. MMP catalytic activity was determined
in solution using fluorogenic gelatin and peptide
substrates, by gelatin zymography in SDS-PAGE
and by in situ DQ-gelatin zymography in RPE/
choroid sections.
Our results demonstrated that CNV volumes
decreased logarithmically with doxycycline treatment. A dosage of 500 mg/kg/day caused a 70
percent (p<0.0005) inhibition of CNV compared
to control animals (Figure 1). Doxycycline elevated PEDF levels in plasma, but did not affect
the plasma pro- and active MMP-2 and MMP-9
levels. However, doxycycline inhibited the
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enzymatic activity of the purified MMP-2 and
MMP-9 enzymes and the in situ gelatinolytic
activities in RPE/choroid sections.
We concluded that doxycycline inhibited the
progression of experimental CNV, elevated the
plasma PEDF protein levels and inhibited the
catalytic activity of MMP-2 and MMP-9 without
affecting their protein levels. These results suggest a potential therapeutic role for doxycycline
as an anti-angiogenic agent.
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The Functional Link between Mitochondrial
Biogenesis and Neuronal Differentiation: Clinical
Implications for Mitochondrial Encephalopathies
Mitochondrial encephalopathies are diseases
caused by mitochondrial dysfunction due to
impaired oxidative phosphorylation, resulting
in decreased energy production in the form of
ATP.1 The brain, a highly energy-dependent
organ, is especially vulnerable to the effects of
the mitochondrial dysfunction in mitochondrial encephalopathies.2 Mitochondrial diseases
are especially challenging due to their diverse
spectrum of manifestations and severity of the
symptoms. It is also difficult to identify genetic
mutations in mitochondrial or nuclear DNA.
Clear basic pathogenetic mechanisms underlying
mitochondrial diseases, as mitochondrial dysfunction gives rise to pleiotropic effects.3,4
As little is known about the functional
link between mitochondrial biogenesis and
neuronal differentiation, our study focused on
the transcriptional regulation of mitochondrial
biogenesis during the early steps of neurogenesis,
more specifically during the transition from
progenitors to differentiating neurons. We used
the cellular paradigm PC12-ND6, a stable cell
line engineered by Anne Chiaramello, PhD,
Department of Anatomy and Regenerative
Biology, The George Washington University
School of Medicine and Health Sciences overexpressing the neurogenic transcription factor
NeuroD6 (ND6), which is critical for the neuronal differentiation of progenitor cells during
corticogenesis. It previously has been shown by
Dr. Chiaramello’s laboratory that NeuroD6 is,
by itself, sufficient to promote spontaneous differentiation and neuronal survival.5 Genomic
studies revealed that NeuroD6 induces the
expression of several mitochondrial genes implicated in oxidative phosphorylation and mitochondrial integrity.6
We investigated the functional link between
NeuroD6 and the NDUFS4 subunit of the mitochondrial complex I, since our genomic studies
showed increased expression NDUFS4 upon
NeuroD6 expression. Furthermore, mutations in
the NDUFS4 gene are frequently associated with
mitochondrial encepalopathies.7
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Our results provide the first demonstration
that mitochondrial biogenesis occurs during
the very early stages of neuronal differentiation,
at the lamellipodia stage preceding axonal and
dendritic outgrowth and development. Our
results also revealed that NeuroD6 is able to
induce mitochondrial biogenesis in a manner
similar to NGF. Finally, we found that NDUFS4
expression levels increased concomitantly with
NeuroD6-induced mitochondrial biogenesis.
Thus, this work suggested that NeuroD6 may
be a potential novel target for mutations associated with mitochondrial encephalopathies.
Collectively, these results may provide molecular
clues regarding the neuro-pathology associated
with mitochondrial encephalopathies.

Jeongae Yoon, MSII

Research Track
Advisor: Anne Chiaramello, PhD,
Department of Anatomy and
Regenerative Biology,
The George Washington
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and Health Sciences.
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Enhanced DNA Repair and Cellular Death Resistance:
A Model for Early Events in Carcinogenesis

Jennifer Anthony, MSII

Research Track
Advisor: Susan Ceryak, PhD,
MBA, associate research
professor, Department of
Pharmacology and Physiology,
The George Washington
University School of Medicine
and Health Sciences.

Figure 1: H2O2-induced

comet tail formation in deathsensitive and death-resistant
fibroblasts. Cells were incubated
with 100 µM H2O2 for 30 min,
and the cells were harvested
and the cell membrane was
permeabilized. The cells
were then embedded in LM
agarose on CometSlides and
electrophoresis was carried
out at 20 V for 30 min. The
slides were then stained
with SyBr Green to visualize
cellular DNA and viewed with
an OlympusIx70 fluorescent
microscope.
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How does a
Death-Sensitive
Death-Resistant
Death-sensitive
Death-Resistant
healthy, normally
functioning cell
become malignant?
The regulation of
cell death conControl
Control
stitutes a critical
response after
carcinogenic genotoxin exposure.1,2 It
is believed that cell
cycle arrest allows
H2O2
sufficient time for
H2O2
surveillance of
damaged DNA,
subsequent repair,
and/or activation
Figure 1:
of apoptotic pathways. However,
many of the early
transforming events that occur in carcinogen“Comet” assay, a technique that measures DNA
strand breaks.5 The respective cell lines were
esis are only now becoming better understood.
exposed to a genotoxin (hydrogen peroxide), folSignaling pathways that regulate apoptosis are
lowing which the cells were immersed in agarose
altered in the process of carcinogenesis, resulting
on a glass slide, the nuclei were selectively lysed,
in enhanced cell survival. Notably, cellular death
and the cells were electrophoresed. During elecresistance is thought to be at the foundation of
trophoresis, broken DNA pieces migrated out of
neoplastic evolution. I learned many aspects of
the nucleus, forming “comets,” which were visualcellular death resistance and its potential relationized with a fluorescent stain. Our experimental
ship to the early stages of carcinogenesis while
conditions specifically allowed for the detection
working in the laboratory of Susan Ceryak, PhD,
of double-stranded DNA breaks, which are lethal
MBA, associate research professor, Department
if unrepaired.
of Pharmacology and Physiology, The George
In a series of experiments, 100 mM hydrogen
Washington University School of Medicine
peroxide
exposure for 30 minutes caused extenand Health Sciences. Her laboratory employs a
sive DNA strand breaks in both death-resistant
clonal population of human fibroblasts that have
and death-sensitive cells compared to the
survived genotoxin exposure and have acquired
untreated control (Figure 1). However, when the
a general resistance to genotoxin-induced clono3,4
cells were allowed to recover for three hours after
genic lethality. These cells have gained selective
removal of the hydrogen peroxide, the deathgrowth advantages that are characteristic of
resistant cells showed markedly reduced DNA
neoplastic cells, resulting in a survival phenostrand breaks, compared to the death-sensitive
type. The goal of the laboratory is to identify the
cells (Figure 2). These results suggest that the
molecular mechanisms underlying this acquired
death-resistant cells undergo greater or faster
resistance to genotoxin-induced cell death.
DNA repair than the death-sensitive cells, which
I tested the hypothesis that cellular death
could be a key determinant of cellular death resisresistance following carcinogen exposure is
tance. Current studies continue to investigate and
associated with altered DNA repair. I analyzed
DNA damage after genotoxin exposure in deathresistant and death-sensitive cells by using the
Carcinogenesis
Continued on p. 13
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Death-sensitive
Death-Sensitive

Death-Resistant
Death-Resistant

Figure 2:
Carsinogenesis

Continued from p. 12

confirm these preliminary data. Future studies
will determine whether the enhanced DNA repair
capacity following genotoxin exposure will lead to
genomic instability in these death-resistant cells.
The results from these present and future studies
will have a substantial impact on our understanding of carcinogenesis and early oncogenesis
as well as significant clinical implications related
to experimental therapeutics.
I would like to acknowledge and thank
Dr. Ceryak and Kristen Wright for their time and
guidance throughout the summer, as well as the
entire laboratory staff.
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clinical practice. . .
Femoral Valgus With or Without Salter Osteotomy is Effective
for Advanced Femoral Head Osteonecrosis in Pediatric Patients
a truly comprehensive examination of the use
of a valgus osteotomy to treat osteonecrosis of
the femoral head in the pediatric and adolescent
population. To explore the efficacy of a valgus
osteotomy in treating AVN in the pediatric
population, we conducted a retrospective study
of 19 children treated with valgus with or
without Salter osteotomies for advanced femoral
head osteonecrosis.
In our cohort, the average age at time of
Brian Kaufman, MSIII
surgery was 9.8 years with an average of 37.5
Advisor: Michael G. Vitale, MD,
months of follow-up. Ten children underwent
Morgan Stanley Children’s
a valgus osteotomy while the remaining nine
Hospital of New York
Presbyterian, New York, NY.
received a combination valgus and Salter
osteotomy. In order to obtain quantifiable
outcome measures, subjective determination
of the children’s pain and activity limitation
was determined from
chart review. Objective
The current literature lacks a truly comprehensive examination of the use of classification of the
children’s pre- and posta valgus osteotomy to treat osteonecrosis of the femoral head in the pediatric operative X-rays was
performed. Goniometric
and adolescent population.
measurements of flexion,
abduction, adduction,
internal, and external rotation were also obtained
outcomes have devastating implications with
from the charts.
AVN accounting for 12 percent of all yearly hip
For many of the children in the study,
replacements (including adult hip replacements).
the most telling subjective measure of their
The treatment consensus in the current
improvement following the valgus osteotomy was
literature focuses on preserving an anatomic
the significant decrease in pain related by the
relationship between the femoral head and the
child. This decrease is best illustrated by the 10
acetabulum, with the explicit goal of avoiding
cases in which pre-operative pain was moderate/
hip replacement in the pediatric and adolescent
severe and improved to mild/none following
population.
surgical correction. Similar findings were noted
The most effective treatment method for
in activity limitation where seven children
AVN in the pediatric population has long been
reported severe activity limitation pre-operatively
debated. Research has proven non-operative
and no limitation post-operatively. Significant
interventions such as bracing ineffective.2
improvement in abduction and external rotation
Surgical procedures including distraction
was also observed.
arthroplasty, varus, and Salter osteotomies have
The results of this study suggest that
been proven effective at delaying hip replacement
proximal femoral valgus osteotomy is an effective
by shifting weight bearing to the healthy portion
of the femoral head.3,4 The current literature lacks
Femoral Valgus
Continued on p. 15
Osteonecrosis, or avascular necrosis (AVN), is
the interruption of blood supply to cortical bone
leading to ischemia, bone death, and the collapse
of weight-bearing joints. The development of
osteonecrosis in the pediatric and adolescent
population is uncommon, but the destructive
pathology of the condition necessitates a
thorough evaluation of the best treatment
options in this population. The vascular anatomy
of the hip makes the femoral head particularly
vulnerable to AVN following interruption
of its blood flow through fractures of the
femoral head and neck, slipped capital femoral
epiphyses, developmental dysplasia of the hip,
and in Legg-Calve-Perthes Disease, among a
variety of other conditions.1 In the pediatric
and adolescent population, poor treatment
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Femoral Valgus

Continued from p. 14

treatment method for osteonecrosis of the
femoral head in the pediatric population. This
study is not a definitive statement on the efficacy
of valgus osteotomy for avascular necrosis of
the femoral head in children and adolescents. It
is, however, a building block for future studies
that can be aimed at determining the precise
indications and contraindications for the
procedure as well as better defining the device
durability.

2.	Herring JA, et al. Legg-Calve-Perthes disease. Part

II: Prospective Multicenter Study of the Effect of
Treatment on Outcome[see comment]. Journal of
Bone & Joint Surgery — American Volume. 2004;
86-A(10):2121–34.
3.

Mont MA, et al. Corrective Osteotomy for

Osteonecrosis of the Femoral Head. Journal of
Bone & Joint Surgery — American Volume, 1996;
78(7):1023–8.
4.	Kitakoji T, et al. Which is a Better Method for Perthes’

Disease: Femoral Varus or Salter Osteotomy?
Clinical Orthopaedics & Related Research. 2005;
(430):163–70.
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Use of a “Hybrid” Locking Plate for Complex Metaphyseal
Fractures and Nonunions about the Humerus
Anatomic location and bone
quality are some factors that
determine the complexity of
fracture patterns. Proximal
and distal humeral fractures
and nonunions are examples
of challenging injuries where
the complex peri-articular
anatomy, small fragment
size of the short bony segments involved, and the
osteopenic quality of the
metaphyseal bone make
stable fixation difficult.1,2,3
Due to these anatomical difficulties, treating surgeons
have sometimes been obliged
to choose between treating
fractures of the proximal
and distal one-third of the
humeral shaft with a smaller,
“weaker” plate that allows
more screws to be placed in
the fracture segments, or a
plate of larger diameter and
greater implant strength with
fewer screws in the short bony
segments. Innovation in locking plate technology
has improved our ability to treat fractures in
osteoporotic bone and the development of “pre-
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contoured” or “anatomically
correct” plate and screw designs
has further advanced the ability
to repair complex peri-articular
fractures.
The purpose of this
retrospective study was to
report on the use of a “hybrid”
locking compression plate,
the Synthes’ Hybrid LCP
Metaphyseal Plate (Figure 1,
Metaphyseal Plate, Synthes,
Paoli, Pa.), that possesses
different size locking holes at
each end, for the treatment of
complex proximal and distal
humeral shaft fractures and
nonunions by a single surgeon
at a regional academic trauma
center. Our hypothesis was
that treatment of difficult
metaphyseal humeral shaft
fractures with this novel
implant would have higher
union rates and lower
complication rates than those
previously reported for similar
injuries treated with conventional locked plating.

Figure 1:

Hybrid Locking Plate

Continued on p. 16
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Figure 1: The Locked

Metaphyseal plate utilized in
this series.
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Figure 2b

Figure 2a

Figure:

2a. An AP trauma slot
radiograph of a 32-year-oldmale who sustained a high
energy distal humeral shaft
fracture and was treated with a
synthes LCP metaphyseal plate.
2b. Post-operative AP radiograph
at three months.
2c. Post-operative lateral
radiograph at three months.
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Hybrid Locking Plate Continued from p. 15
Our cohort consisted of 21 patients with
humerus fractures who were treated over a twoyear period. Fourteen acute fractures and seven
nonunions were identified in the study cohort.
Our cohort consisted of six men and 15 women
with a mean age of 49 years. All fractures were
secured with a “hybrid” locking plate with a
minimum of three 4.5mm screws on one side of
the fracture and three 3.5mm screws on the other
side (Figure 2). All patients were treated with a
similar post-operative protocol for early range of
shoulder and elbow motion.
All patients in our cohort healed their fracture or fracture nonunion demonstrating satisfactory functional and radiographic results. The
mean time to union following surgical intervention was 4.5 months (Range 3-6). There were no
implant-related complications and no small screw
failures in this series. The metaphyseal locking
plate seems to be ideal for situations in which it
may be advantageous to place a greater number
of screws within a small segment of bone, such as
certain difficult fractures of the meta-diaphyseal
humeral shaft.

Figure 2c

We concluded that the Hybrid LCP
Metaphyseal Plate is a useful new implant that
maximizes the advantages of locked compression plating in the treatment of certain difficult
proximal and distal one-third fractures of the
humerus that are not amenable to traditional
plate and screw fixation. Meta-diaphyseal upper
extremity long bones may serve as the most
ideal location for this implant. Our retrospective analysis provides clinical verification of our
hypothesis and indicates that treatment of this
category of fractures is a promising new application for the LCP Metaphyseal Plate.

REFERENCES
1.	Lever JP, Aksenov SA, Zdero R, Ahn H, McKee M, Schemitsch
EH. Biomechanical Analysis of Plate Osteosynthesis

Systems for Proximal Humerus Fractures. J Orthop
Trauma. 2008; 22(1):23–9.
2.	Ring D, Jupiter JB. Complex fractures of the distal

humerus and their complications. J Shoulder Elbow
Surg. 1999; 8(1):85–97.
3.	Ring D, Kloen P, Kadzielski J, Helfet D, Jupiter JB. Locking

compression plates for osteoporotic nonunions of the
diaphyseal humerus. Clin Orthop Relat Res. 2004;
(425):50–4.

Fusion • 2009

The Accuracy of a New External Anatomical Landmark on
Visualization of Target Organs during the FAST Ultrasound Exam
The use of ultrasonography in
trauma patients to assess the
severity of intra-abdominal
injury has become a frequent
practice in surgery and emergency departments. With the
development of the Focused
Assessment with Sonography
for Trauma (FAST) examination in 1996, surgeons and
emergency physicians in the
U.S. began using ultrasound as
a faster, noninvasive method to
evaluate abdominal trauma.1
The FAST exam is currently
used extensively as a diagnostic tool for detecting
fluid in the pericardium and peritoneum, indicating serious injury (Figure 1).2
The current standard practice of ultrasound
probe placement in the FAST exam for the
right upper quadrant (RUQ) is to position the
probe at the right midaxillary line between the
10th and 12th ribs where liver, right kidney,
diaphragm, and Morrison’s pouch should be
identifiable in a coronal view. Similarly, the left
upper quadrant (LUQ) probe position is at the
left posterior axillary line between the 10th and
12th ribs where spleen, left kidney, diaphragm,
and splenorenal recess should be identifiable.
According to available literature, flawed
techniques and provider inexperience often have
detrimental effects on imaging procedure.2
The application of a simpler, more straightforward method of performing the exam using
easily identifiable landmarks may improve
technique and enable less experienced physicians
to complete the exam faster and more precisely.
The purpose of this study was to establish two
external anatomical landmarks, the hepatorenal
point (H point) for the RUQ and the splenorenal
point (S point) for the LUQ, to be used by novice
operators to accurately complete the FAST exam
in an emergency situation to generate instantaneous images of the target organs that are diagnostically adequate in patients. The H point is
the intersection of the horizontal subxiphoid line
and right midaxillary line; while the S point is
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Figure 1: An ultrasound image of right upper quadrant showing
a positive FAST result. Intraperitoneal fluid can be seen in Morrison’s
Pouch.

Emergency Management Track
Advisor: Hamid Shokoohi,
MD, MPH, clinical instructor,
Department of Emergency
Medicine, The George
Washington University School of
Medicine and Health Sciences.

the intersection of horizontal subxiphoid line and
left posterior axillary line.
In the first phase of the study, providers
(medical students and residents) were trained
to perform the FAST exam using the proposed
external landmarks. Medical students also completed a pre- and post-test questionnaire to evaluate their learning curve. In the second phase,
providers performed the FAST exam in the
emergency department under the supervision of
credentialed attending physicians. Adjustments
necessary to obtain an adequate view of target
organs away from the initial landmark-predicted
points were recorded.
The site predicted by the landmark revealed
the requisite organs at a rate of 82.4 percent at
first attempt without need for further probe
movement. There was a significant difference
in precision rate between H and S points, at
89.6 percent and 75.2 percent respectively
(p < 0.01). In patients with BMI>30, providers
had more challenges in visualizing the LUQ
target organs by following the landmark, however, providers with more than 10 previous FAST
experiences did not encounter such difficulties.
In conclusion, the study results demonstrate
that the H and S landmarks serve as simple and

Anatomical Landmark Continued on p. 18
17

Anatomical Landmark Continued from p. 17

REFERENCES:
1.	Rose J. Ultrasound in Abdominal Trauma. Emer-

precise guides that can facilitate the teaching and
performance of the FAST exam in the hands of
inexperienced providers, including pre-clinical
and clinical medical students.

gency Medicine Clinics of North America. 2004;
22(3):581–599.
2.	Dente C, Rozycki G. Chapter 13, Ultrasound for Sur-

geons. In Townsend: Sabiston, Textbook of Surgery.
18th ed. Saint Louis: W.B. Saunders; 2007.

Sexual Dimorphism in Humeral Bone Volume
in the Young Adult Skeleton
Bone volume is the result of a complex interaction of genetic as well as environmental factors.1 For example, mechanical loading is an
environmental factor that has been shown by
experimental and observational data to affect
bone size in a concept called “bone functional adaptation.”2 Data from the Functional
Polymorphisms Associated with Human Muscle
Size and Strength (FMS) study,3 a multi-center
study designed to evaluate the effects of genetic
polymorphisms on bone geometry, fat volume,
and muscle size and strength, offers the opportunity to investigate the relationship between
bone volume and body weight, height, muscle
size, and muscle strength (both isometric and
isokinetic measurements), all potential sources
of mechanical loading. The FMS study chose
to investigate the humerus for several reasons,
including its particular sensitivity for detecting
genetic predisposition in bone and muscle health,
as well as being a single bone and thus not subject to load sharing. It is also not weight-bearing

Caucasian subjects, male (n = 205) and female
(n = 327). Subjects were between 18 and 40
years of age (males mean age = 23.9 ± 5.7,
females = 22.8 ± 5.2). Muscle size (volume), and
bone volume were determined from Magnetic
Resonance Images (MRI) of the distal 9.6 cm
Adrian A. Woo, MSII
of the humeral diaphysis using semi-automated
Contributors:
Elizabeth L. Greene, MSII;
software from Rapidia®. Muscle strength was
Karl J. Jepsen, PhD;
determined using both dynamic and isometric
Heather Gordish-Dressman, PhD;
strength testing.
Cinzia Brandoli, PhD;
Both total bone volume and cortical bone
Eric P. Hoffman, PhD;
volume was found to be highly correlated with
Joseph M. Devaney, PhD;
weight in both males and females (Figure 1).
Interestingly, the correlation was stronger
Principal Investigator:
between male bone size and weight (r2 = 0.27)
Laura Tosi, MD,
than in female bones (r2 = 0.19). The differChildren’s National
ence between the sexes was even greater when
Medical Center,
comparing bone size to muscle strength, in both
Washington, D.C.
isometric and dynamic strength tests (Figure 2).
Muscle volume is often considered representative
of muscle strength in current research, however
we found that while muscle volume did correlate with muscle strength, it
did so at a lower than expected
The young adult population of the FMS study gives a snapshot of the level, r2 = 0.22, meaning only
adult skeleton at the peak of bone growth in both males and females. 22 percent of muscle strength
could be accounted for by its size.
In addition, they correlated differently when compared to bone size, with muscle
and is therefore less affected by confounding
strength correlating more strongly than muscle
factors such as fluctuations in weight or activity.
volume with bone size. Again, these relationHowever, the environment does play a substanships were found to be stronger in men than in
tial role in humerus bone development. The
women.
objective of this study was to find correlative
These results provide strong evidence that
evidence that bone volume is affected by factors
mechanical loading has a significant influence on
of mechanical loading and then investigate how
bone volume. The young adult population of the
sex modulates that influence in a population of
FMS study gives a snapshot of the adult skeleton
young, healthy adult males and females.
at the peak of bone growth in both males and
In this study measures of bone volume,
muscle strength and size of the dominant and
non-dominant humerus were determined in
Sexual Dimorphism
Continued on p. 19
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Figure 1: Total Bone Volume vs. Weight in Females and Males.

Figure 2: Dynamic Strength (one repetition max: 1-RM) vs. Total Bone Volume in Females and Males.

Sexual Dimorphism

Continued from p. 18

females. It also provides evidence of the endresult of the effects of mechanical loading factors
including body weight and muscle strength, on
the growth of the skeleton. Our study shows a
clear difference within this population in the
correlation between bone volume and the measurements of body weight and muscle strength
between males and females, possibly showing the
effects of sex on bone growth. Since females tend
to stop adding bone on the periosteal surfaces
after puberty, the stronger correlations found
in this study between bone size and mechanical
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stress in males clearly reflect the difference in
growth patterns between genders.
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Bone morphogenetic proteins (BMP), the only
proteins known to have the osteoinductive
capacity to generate new bone formation,
were first isolated from bone 20 years ago.1
BMPs are the focus of numerous studies
seeking alternatives to the morbidity associated
with autograft bone. In fact, studies have
demonstrated that BMPs are a safe and effective
alternative to allograft and autograft bone.1,2 Two
such BMPs, BMP 2 and BMP 7, are typically
used independently. However, recent in vitro and
animal studies have investigated a synergistic
effect when BMP 2 and BMP 7 are combined.3,4
No clinical studies have investigated the use
of combining BMP 2 and BMP 7 in lumbar
fusions. Before addressing the efficacy of this
combination in humans, it is important to
establish the safety of combining these two
materials in spinal surgery. This retrospective
study aims to determine the prevalence of
complications associated with combining BMP 2
and BMP 7 in posterolateral lumbar fusions.
The study followed a cohort of patients who
received a combination of BMP 2 and BMP 7 in
posterolateral lumbar fusions. Medical records
were reviewed to determine the prevalence of
post-operative complications such as infection,
inflammation, hematoma, nerve damage, ectopic
bone formation, and allergic reactions. Potential
post-operative complications were compiled from
the package inserts of BMP 2 and BMP 7 as
reported by their manufacturers. Patients were
followed for an average of 4.5 months.
Cross-referencing the medical records of
patients who had received BMP 2 and BMP 7
in posterolateral lumbar fusions revealed that
29 of 30 patients (97 percent) showed no postoperative complications associated with the
combined BMP 2 and BMP 7 implant. One
patient developed an infection at the surgical site
that was cleared by oral antibiotics. There were
no other cases of adverse events.
The results from this study suggest that
patients who receive both BMP 2 and BMP 7
in a posterolateral lumbar fusion are not at any
significant risk for complications arising directly

from this combination. Future applications
include studies seeking to measure the efficacy of
this combination as well as to investigate other
combinations that may be safely and effectively
used to increase success rates in posterolateral
lumbar fusions.
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Muscle Pain Detection Device in Properly
Diagnosing Back Pain
Regardless of their occupation, socioeconomic
thus altering its activity, which in turn allows the
status, or ethnicity, patients can often experience
physician to identify which muscles are inducing
back pain at various times in their lives. Back
the pain.
pain can range from minor to severe excruciating
By utilizing the MPDD, physicians can have
pain.
access to a more reliable and valid evaluation of
Mourad Shehebar, MSII
Unfortunately, there are a large number of
muscle pain. To investigate these results, a ranAdvisor: Corey W. Hunter, MD,
patients whose pain is not alleviated by current
domized controlled study of MPDD vs Manual
Pain Management,
physician interventions.
Pressure was conducted. Forty patients with a
New York University Langone
Dr. Norman Marcus, founder of The
three month history of back pain were divided
Medical Center, New York, NY.
Norman Marcus Pain Institute (NMPI), chalblindly into two groups. Within each respective
lenges the well-accepted diagnostic and treatgroup, MPDD or Manual Pressure was utilized
ment tools for addressing back pain. In focusing
to identify the muscles creating the source of
on a more accurate way to diagnose, Dr. Marcus
pain. All subjects were injected with 5 percent
believes that the patients not benefiting from
Lidocaine. Preceding the treatment along with
current methods of pain relief
are not incurable but are instead
In order to combat … diagnostic difficulties, a Muscle Pain Detection
misdiagnosed. Many physicians
do not realize that back pain
Device (MPDD) has been formulated. The MPDD, a small device,
is the result of muscular injury
uses electricity to harmlessly promote a muscle contraction on selected
as opposed to neurovascular.
Dr. Marcus enhanced the
muscles thus altering its activity, which in turn allows the physician to
techniques to evaluate and treat
identify which muscles are inducing the pain.
muscle pain taught to him by
Hans Kraus, MD, father of
sports medicine and back pain
one week and one month afterwards, the patients
specialist to President John F. Kennedy.
Painful muscles may develop hardened areas
were given a physical exam and were asked to
of taut muscle fiber, or “trigger points,” that are
complete Oswestry and Visual Analogue Pain
quiet at rest but if stimulated will produce pain.
Scale questionnaires.
Various approaches have been suggested to treat
For both follow-up visitations, the MPDD
these painful knots. The widely used method in
group had an overall statistically significant
determining the location of these painful nodimprovement in mood, disability, and back pain
ules is manual pressure via hand palpations. At
(P < 0.004 - 0.001). At one month, there was a
these points, physicians tend to inject 5 percent
53.2 percent reduction in pain in the Manual
Lidocaine (numbing agent), steroids, or just a dry
Pressure group compared to the astounding 82.5
needle stick, which would all serve to relax the
percent (P < 0.001) pain relief in the MPDD
muscle and possibly the nerve.
group.
Manual pressure to identify trigger points
This study could revolutionize how back pain
does not adopt consistent reliability between
is perceived in the future. The MPDD should
different examiners. In addition, the palpations
allow physicians to accurately diagnose the origin
are being conducted upon resting muscles, which
of the muscle pain and treat it more successfully.
will not elicit the accurate response as it would in
In appreciation to this investigation, back pain
an active muscle. In order to combat the aforeno longer has to possess an elusive diagnosis.
mentioned diagnostic difficulties, a Muscle Pain
References:
Detection Device (MPDD) has been formulated
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mote a muscle contraction on selected muscles
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Preterm birth, defined as birth occurring earlier
than 37 weeks gestational age (GA), is an increasingly important public health concern in the
United States as the percent of preterm births has
risen to 12.6 percent of all births in 2005.1 Very
preterm infants have significantly higher rates of
cognitive impairment, sensory deficits, cerebral
palsy, motor delay, and educational and social
difficulties. Magnetic resonance imaging (MRI)
examination for radiological abnormalities frequent in preterm newborns — intraventricular
hemorrhage, periventricular leukomalacia, and
other white- and grey-matter abnormalities — is
predictive of these deficits.2
This study examined both preterm and
term infants using a recently-employed imaging
technique, functional connectivity MR, which
examines spontaneous functional MRI (fMRI)
signal fluctuations at rest. Functional connectivity
has been extensively studied in adults and several
regions have been identified as components of a
“default mode network,” or DMN. The DMN
is a group of neuroanatomical regions that are

Figure 1: Representative examples of correlation maps generated by comparing seed regions (noted

on left) to the individual subject’s fMRI at-rest. Seeds placed in the posterior cingulate cortex showed
functional connectivity with the prefrontal cortex (arrows) in all groups and indicates elements of the DMN.
Term infants had greater bilateral connectivity shown in the primary auditory cortex, primary motor cortex,
and somatosensory cortex.

thought to function together and have been
hypothesized to form the basis of cognition and
self-referential thought, as indicated by synchronous signal fluctuations identified by fMRI, PET,
and EEG of resting individuals.3 This resting-state
network has been found to differ in children,
who possess less connections than adults, and was
shown to deteriorate in aging and Alzheimer’s
disease, thereby intimating its functional importance.4,5 Only one study has been conducted in
infants, who were preterm newborns scanned at
term-equivalent age; this study found that infants
did not appear to have a DMN similar to adults.6
Our study addressed two questions: first, do
infants possess any elements of the DMN seen in
adults, and second, do preterm infants show different patterns of resting-state activity? To answer
these questions, we utilized a seeds-based correlational method, which looks at the fMRI timecourse within a selected region of the brain and
compares it to the rest of the brain. If a disparate
region has a similar pattern of signal over time,
it is thought to be functionally connected to the
region chosen. Results are depicted in Figure 1.
We identified one component of the adult
DMN in both preterm and term infants, the
anteroposterior connection between prefrontal
cortex and posterior cingulate cortex. This
finding differs from that of a previous study
in infants and indicates that infants may have
greater maturation in the DMN than previously
thought.6 There was no apparent difference in
resting state activity when comparing GA, but
our study was limited to a set of 14 infants,
four of which were term controls. Another
important finding was that term infants
showed greater interhemispheric correlations
in functionally related regions such as the
primary auditory, motor, and somatosensory
cortices, whereas preterm infants had largely
unilateral correlations. These findings have
been demonstrated in EEG studies and suggest
that, although interhemispheric anatomical
connections exist much earlier, preterm
infants may not have functional networks
across hemispheres.7 Functional connectivity

Infant Brain
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Infant Brain

the default mode brain network. PNAS. 2008;
105(28):9781–6.

Continued from p. 22

may facilitate a greater understanding of the
mechanisms by which the brain functions and
how the disruption of this connectivity reflects
deficits in cognition and functional impairment
seen in preterm infants later in life.

4.

Architecture of the Brain’s Default Network. PNAS.
2008; 105(10):4028–32.
5.	Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode

network activity distinguishes Alzheimer’s disease
from healthy aging: evidence from functional MRI.
PNAS. 2004; 101(13):4637–42.
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Consistency and functional specialization in

Use of Trabecular Metal Implants in Anterior Cervical
Discectomy and Fusion: A Two-Year Retrospective Study
Anterior cervical discectomy and fusion (ACDF)
is a surgical procedure indicated in the treatment
of compression injury in the cervical spine as
a result of degenerative disc disease and herniated discs. ACDF is designed to restore strength
and stability to cervical vertebrae through the
removal of damaged or diseased intervertebral
discs and insertion of fusion-promoting bone
grafts or synthetic interbody cage devices.
Successful vertebral fusion results in restored
intervertebral disc height, alleviation of spinal
cord compression, maintenance of cervical lordosis, and reduction in pain.1
Bone grafts, the implants of choice since the
first ACDF was performed in 1953, have recently
fallen out of favor due to complications such as
graft expulsion, pseudarthrosis, and increased
infection risk at the harvest site.2 In particular,
autologous bone grafts are associated with
increased donor-site morbidity.3 Allograft bone
grafts, while eliminating donor-site complications, are associated with inferior fusion rates.2
Synthetic interbody cages, such as trabecular
metal implants, intend to eliminate the complications of bone grafts while providing the benefits of intervertebral fusion. The use of trabecular
metal implants has increased in the past decade

Fusion • 2009

due to its comparable characteristics to cancellous bone.1 Trabecular metal is a highly porous
composite of tantalum metal and vitreous carbon
with inherent osteoconductive characteristics,
such as high volumetric porosity, high frictional
characteristics, excellent corrosion and erosion
resistance, and a low modulus of elasticity. These
features, which closely resemble cancellous bone,
enhance the biocompatibility of the metal and
promote rapid vascularization and tissue infiltration at the site of fusion.1
The primary objective of this study was to
validate the use of trabecular metal implants in
ACDF by measuring and comparing preoperative and 24 months postoperative clinical and
radiographic outcomes. The two-year mark was
established to ensure spinal fusion could be successfully determined and degeneration had not
occurred at levels above or below the implant
(a common problem with allograft implants).
Inclusion criteria focused on male and female
patients, ages 30 to 90 years old, who underwent
either a single or multi-level ACDF with trabecular metal implants during the study period
from May 2004 to September 2008. The primary
radiographic endpoint was evidence of fusion,

Trabecular Implants
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Trabecular Implants Continued from p. 23
which was determined by percentage of lucency
at each vertebral body, Cobb angle analysis,
change in hardware position, spinous process
motion in flexion/extension views, and percent
lordosis change at each vertebral level. Initial
radiographic analysis indicated all 30 patients had
complete fusion at 24 months with no need for
revision surgery. Primary clinical endpoints were
obtained comparing preoperative and 24-month
survey scores from the SF-36, the Neck Disability
Index (NDI), and the Visual Analog Scale (VAS).
The SF-36 measures functional social, physical,
and mental health using a 100-point scale.
Initial survey data indicated improvements of
13.3 points and 13.2 points in the physical and
mental component scores, respectively. The NDI,
also using a 100-point scale, noted a 33.8-point
reduction in neck disability. Additional analysis

is ongoing, but the positive fusion rates and
improved clinical outcome data suggest the use
of trabecular metal implants in ACDF should be
explored further as a viable alternative to bone
grafts.
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Language dominance
appears to be established between four to
seven years, but few
functional Magnetic
Resonance Imaging
(fMRI) investigations
focus on development
of functional connectivity of language
Figure 1: Group activation maps display areas of activation during the auditory description decision
networks in healthy
task. Regions of interest selected for study included the L-IFG (Broca’s area), L-MFG, L-MTG and L-STG
children known to
(Wernicke’s area), and right sided homologues. Left-sided activation predominates, reflecting lateralization
engage receptive (lisconsistent with age-dependent development.
tening) and expressive
(speaking) language
regions. Functional connectivity is defined as the
Paired regions were also compared across age
temporal correlation between spatially remote
groups, in relation to neuropsychological meaneurophysiological events.1
sures, and behavioral data.
We performed a cross-sectional functional
Significant connectivity by age group interacconnectivity analysis on fMRI data collected
tion was found for L-IFG (p=0.03) and L-MFG
from an auditory description decision task from
(p=0.01). Post hoc analysis revealed age-related
58 normally developing right handed children
trends indicating 4–6 year-old children have
aged four to 12 years. The active condition
less connectivity between L-IFG and L-WA
requires a semantic decision based on a word
than both 7–9 year-olds (p=0.08) and 10–12
definition while the control condition consists of
year-olds (p=0.11). There was also an age-related
reverse speech with tone identification. Regions
trend for 4–6 year-old children having more
of interest implicated in language-processing —
connectivity between L-MFG and R-MFG than
the left inferior and middle frontal gyri (L-IFG
the 10–12 year-olds (p=0.07). We found strong
and L-MFG), Wernicke’s area (L-WA), and right
connectivity between homologous regions that
hemispheric homologues — were examined.
persisted across age groups (IFG r=0.6437; MFG
Functional connectivity was measured between
the left networks and their right homologues.
Language Processing Continued on p. 25
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Figure 2: Relationaship
of age to connectivity
(Pearson’s r-value).

Language Processing Continued from p. 24
r=0.7207; WA r=0.7152). The L-IFG—L-WA connection positively correlated with expressive one
word vocabulary (EOWV) (p=0.02) and trends
were found for the WA and IFG homologues with
other neuropsychological tests. There were no
significant differences for behavioral measures.
The modest age-related findings reflect
known anatomical and structural developments.
Specifically, the greatest age-related changes
occurred in the L-IFG and L-MFG, regions that
demonstrate extended periods of maturation.2
Additionally, the greater connectivity between
left Broca’s area and left Wernicke’s area in the
7–9 and 10–12 year-olds relative to the 4–6
year-olds, reflects strengthening of that network,
perhaps due to pruning of redundant or less
utilized networks and consolidation.3 This reveals
a mature arcuate fasciculus, the primary connection demonstrated in anatomical studies.4 The
decrease in the L-MFG—R-MFG connection
may represent the lateralization of attention and
working memory functions that normally occurs
with increases in age in right-handed individuals.5
The protracted development of the frontal lobe
may explain the significant age group interactions
found in the L-IFG and L-MFG, while connections solidified outside this age range appear
age-invariant.6 Connectivity correlations with
performance on the EOWV test may reflect the
observation that Broca’s area matures earlier than
the more posterior language cortices7 leading
to more conspicuous age-related changes in the
expressive task within this pediatric population.
Strong connections between homologous regions
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suggest a great deal of cross-talk, even after laterality has been established, which may represent
left networks modulating the activity of their
right homologues, task-dependent recruitment,
or inter-hemisphere connections that serve as a
reserve in the setting of injury.
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Systemic lupus erythematosus (SLE) is a chronic
autoimmune disease, whose prognosis can be
influenced by environmental factors. The importance of access to care and its effects on SLE
outcome is not well defined in the literature and
measures of access have varied widely between
studies. The first five years of the Lupus in
Minorities: Nature Versus Nurture (LUMINA)
longitudinal study indicated a perceived difficulty
in obtaining health care to be more frequently
reported in SLE patients who subsequently died
(21.4 percent) compared to surviving patients
(3.8 percent, p = 0.002).1 Treating early in disease
onset and closer follow-up visits were hypothesized to contribute to improved survival in
SLE.2 Universal health care in Canada provides
a unique setting for our investigation by minimizing effects of income on access. Therefore
this study was designed to determine whether
care barriers are associated with increased disease
activity and damage in a multi-center, multiethnic Canadian SLE cohort. We also compared
concordance between care barriers as reported by
the patient and lupus specialist.
This was a retrospective study using data from
14 Canadian centers with annual visits from
patients with SLE. The patients’ prognosis was
evaluated based on self-reported access to care.
Access to care measures included availability
of a family physician, financial barriers such as
affording medication, and perceived difficulties
in accessing rheumatology clinics and medications. Data including demographics, treatment,
disease activity, and damage were analyzed.
Damage was assessed using the SLICC ACR
damage index developed by the American College
of Rheumatology. Patient-reported access to
care included availability of a family physician,
financial barriers, and perceived difficulties in
accessing rheumatology clinics and medications.
We also compared patient’s assessment of care
barriers they believed they faced, to what barriers
their physicians thought might be impeding the
patient’s access to care.
Our patient population extracted from the
Canadian “1000 faces of Lupus” database consisted of 654 patients. It is important to note that
all patients had access to a lupus specialist yet

many still faced barriers to care. Just over half
(50.8 percent) of the patients perceived a care
barrier despite universal health care in Canada;
27.5 percent found cost of medication as a barrier
to care, 19.6 percent reported waiting to see a
rheumatologist as a barrier, 32 percent reported
traveling to a rheumatologist’s office as a barrier,
7.6 percent reported access to medication as a
barrier and 8.6 percent reported cost of medical
devices as a problem.
Doctors and patients did not seem to identify
similar care barriers (r = 0.09). Doctors correctly identified only half the patients who had
access to medication problems (p = 0.003). Lack
of access to medication and costs were significantly associated with co-morbidity (p < 0.001,
p = 0.04). Access to medication from the physician’s perspective was positively associated with
SLE Disease Activity Index (p = 0.03) and cost of
medication (p = 0.04). Physician perceived barrier
of access to medication was associated with SLE
activity (β = 1.14, p = 0.001).
We concluded that access to a lupus specialist
does not necessarily imply adequate access to
health care. Care barriers are important for
lupus outcomes and are grossly underestimated
by physicians. In health care it is essential for
physicians to consider and recognize barriers to
care when trying to improve the health status
of their patients. More emphasis in physician
training needs to be placed on recognizing and
accommodating for these barriers in patient care.
This study was a “best case scenario” where lupus
patients were seeing a specialist and thus were
entered into a lupus registry. This is unusual in
the lupus population and especially in the United
States where there are gaps in health insurance
and thus the barriers to care are likely to be far
greater.
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research & travel abroad. . .
A Neglected Tropical Disease: Hookworm Up Close
and Personal in Americaninhas, Brazil
Neglected tropical diseases (NTDs) impose a
great burden on the global population, especially
those living in poverty. Approximately one billion
people are infected by one or more of the NTDs.
Together, these diseases account for a greater
portion of the total global Disability Adjusted
Life Years (DALYs ) than tuberculosis or malaria
combined. Of these diseases, human hookworms
infect up to 576 million people worldwide. The
majority of these infections are by the Necator
americanus and Ancylosoma duodenale species
and occur mostly in sub-Saharan Africa, China,
Southeast Asia, and Latin America.
The impact of infection is greatest in children
and pregnant women. Hookworm infection
presents as severe anemia when the larvae embeds
itself into the host intestinal wall, constantly
causing cell injury and blood loss. There is
stunted physical and cognitive development in
children. Infected pregnant women have higher
mortality and morbidity, as they are already
anemic; the fetus is indirectly harmed.
Hookworm is easily treatable with oral
medications such as Albendazole. However, high
reinfection rates necessitates the development of
an efficacious and cheap vaccine to be developed.
Consequently, the Sabin Institute’s Human
Hookworm Vaccine Initiative (HHVI), in collaboration with The George Washington University
and Fundação Oswaldo Cruz, is conducting
a hookworm vaccine clinical trial in the rural
town of Americaninhas, Brazil. Americaninhas is
located in a rural area approximately 500km from
HHVI’s laboratory in Belo Horizonte.
My primary role at the Americaninhas site
was to shadow the HHVI physician as she rotated
between various clinics during her monthly visit
to the area. Rural residents do not have ready
access to care, therefore, both HHVI and nonstudy patients are seen. In contrast to how medicine is practiced in the United States, the HHVI
physician focuses solely on the history and the
physical exam. Lacking modern diagnostic tools,
we used only a stethoscope, sphygmomanometer,
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and thermometer. I conducted the heart, lung,
and abdominal exams. Many patients presented
with conditions I will never see in the U.S. For
instance, a family of eight was diagnosed with
polyinfections of hookworm, ascaris, and schistosoma. A young woman complaining of joint
pains and fever was diagnosed with dengue fever
using only a sphygmomanometer. Virtually every
patient we treated was infected with hookworm,
underscoring the need for a vaccine.
The remainder of my summer was spent in
the Belo Horizonte laboratory where I conducted
Hemoquant and ELISA assays. Hemoquant
quantifies hemoglobin in the feces of hookworm
infected individuals. The primary goal of the
project was to standardize the number of hookworm eggs to hemoglobin detected in feces by
analyzing 1,000 fecal samples collected from
patients living in
Americaninhas and
surrounding towns.
Another project was
to conduct ELISA
assays and detect
antibody response to
a hookworm antigen.
My experience
in Brazil allowed me
the opportunity to
interact with unique
patients and work
on a vaccine clinical
trial while learning
about the Brazilian
culture, language,
and health care
system.
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The human immunodeficiency virus (HIV) has
defied a quarter century of attempts to create a
safe and effective vaccine.1 More than 100 candidate vaccines have been evaluated in various
stages of clinical trials; all of which have failed.2
Recently, federal officials halted plans to advance
a promising new HIV vaccine into a large clinical
trial; the consensus being that researchers need
to return to the bench before again proceeding
to the bedside.3 This current state of affairs
has significant implications for future investment and progress in HIV vaccine research and
development.
In order to work, a protective HIV vaccine
must teach the body’s immune system to recognize specific viral proteins and to attack both the
virus itself as well as virally-infected cells. Early
efforts focused on the HIV envelope proteins,
which represent the targets of neutralizing antibodies produced by B-cells.4 These viral surface
proteins are often highly variable, however, owing
to the highly mutagenic nature of HIV. This
means that a vaccine must invoke an exceptionally broad immune response in order to be effective.5 In more recent efforts, as the importance of
T-cell responses in the control of HIV infection
became appreciated, researchers broadened their
scope to evaluate vaccines that incorporated
the more conserved internal proteins of HIV.4
Although only antibodies can actually prevent
infections by neutralizing the virus itself, a vaccine that aims to harness T-cells would theoretically keep the viral load in check and prevent the
progression from HIV infection to AIDS.6 Over
time, this strategy might even deplete the viral
load due to incomplete replication of the virus
within cells that are being killed. However, this
approach is also inherently problematic because
HIV selectively infects the CD4+ subset of
T-cells, which are critical in initiating and maintaining an adaptive immune response.
Most of the early efforts in HIV vaccine
research and development were spearheaded
by the pharmaceutical industry, but as the
likelihood of a quick success decreased, private
investment began to wane.7 At that time, HIV
vaccine research began and continues to follow
a somewhat atypical paradigm, with the public

sector supporting a greater share of all phases
of research and development. Throughout this
period, the public sector has been trying to
employ mechanisms to engage industry while
continuing to support investigator-driven research
within academia. In 2004, three-quarters of all
global expenditures for HIV vaccine research and
development were estimated to have come from
the U.S. government.4 Still, the National Institute
of Allergy and Infectious Disease (NIAID) —
the division of the National Institutes of Health
(NIH) that undertakes most of the publicly
supported HIV/AIDS research — devoted only
28 percent of its HIV research funding to HIV
vaccine research efforts.
Scientific uncertainty appears to be the most
important reason for low investment in HIV
vaccine research and development.7 There is an
exceptionally poor understanding of the immune
response needed for successful protection from
HIV. Due to the inherent complexity of the situation with HIV, members of industry are largely
unwilling to expose themselves to this degree of
financial risk and potential for failure, especially
when a substantial reward is unlikely. Vaccines,
in general, have a more limited market and lower
return on investment compared to therapeutic
drugs. In this case, potential sales of all vaccines
in the worldwide HIV space are estimated to
represent only about $6.5 billion annually, or 2
percent of the global pharmaceutical market, an
amount that is roughly equivalent to the sales of
one successful ulcer drug.8
In order to increase private investment in this
space, there will probably have to be a combination of push strategies, which reduce the cost and
scientific risk of investment, and pull strategies,
which guarantee a viable market. While push
strategies are particularly important during this
early stage of vaccine development, pull strategies will become important for poorer markets
once the scientific problems have been solved.
Unfortunately, the vicious cycle of HIV vaccine
research and development will likely persist for
quite some time, as scientific and fiscal barriers
make industry reluctant to invest in the basic
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science research and clinical trials that are
required to solve them.
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